Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill aligning Arkansas with FDA guidance to allow specialty compounders to sell to pharmacies
Summary
House Bill 1801, as amended, would permit specialty compounding pharmacies to sell certain products to retail pharmacies when the FDA has deemed a product commercially unavailable or on the FDA shortage list; the committee passed the bill after adopting an amendment directing the Board of Pharmacy to promulgate labeling rules.
State Representative Kendra Moore (District 23) told the Senate committee that House Bill 1801 allows specialty compounding pharmacies—facilities that are licensed and regulated to meet higher manufacturing standards—to sell medications to retail pharmacies for patient dispensing when a product is not commercially available and appears on an FDA shortage list.
Moore said the FDA…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
